Kim G. Adcock, PharmD
Professor
Department:
SOM-Peds-Clinical Research
Email:
kadcock@umc.edu
Work Phone:
(601) 984-2760
Biography
Dr. Adcock received her Doctor of Pharmacy degree from the University of Mississippi in 1996 and subsequently completed an ASHP-accredited Pharmacy Practice Residency and a Pediatric Specialty Residency at the University of North Carolina. Upon completion of her post-doctoral training, Dr. Adcock joined the faculty at Louisiana State University – Shreveport, Department of Pediatrics and practiced in a NIH funded Pediatric Pharmacology Research Unit. In 2002, she joined the faculty at the University of Mississippi School of Pharmacy. Dr. Adcock is currently a Tenured, Associate Professor of Pharmacy Practice and Professor of Pediatrics. She is also the Director of Pediatric Clinical Research with the Department of Pediatrics.
Education
| University of North Carolina Hospitals, Residency, Pediatric Specialty Resident | 1998 |
| University of North Carolina Hospitals, Residency, Pharmacy Practice Resident | 1997 |
| University of Mississippi, PharmD, Pharmacy | 1996 |
| East Central Community College, Associate in Science, Pre-Pharmacy | 1992 |
Specialty Certification Licensure
| Certification, Certified Clinical Research Coordinator, Association of Clinical Research Professionals | 2000 - Present |
| Licensure, Pharmacist, Mississippi Board of Pharmacy | 12/1997 - Present |
| Licensure, Pharmacist, Louisiana | 06/1998 - 12/2005 |
| Licensure, Pharmacist, North Carolina | 07/1996 - 12/2005 |
Current Positions
| Professor, School of Medicine, Department of Pediatrics | 07/2014 - Present |
| Associate Professor, School of Pharmacy, Department of Pharmacy Practice | 07/2008 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 07/2009 - 06/2014 |
| Assistant Professor, University of Mississippi School of Pharmacy, School of Pharmacy, Department of Pharmacy Practice | 05/2002 - 06/2008 |
| Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Pediatrics | 05/2002 - 07/2009 |
| Assistant Professor, Louisiana State University Health Sciences Center - Shreveport, School of Medicine, Department of Pediatrics | 2002 - 05/2002 |
| Associate Clinical Pharmacologist, Louisiana State University Health Sciences Center - Shreveport, School of Medicine, Department of Pediatrics | 1999 - 2000 |
| Instructor, Louisiana State University Health Sciences Center - Shreveport, School of Medicine, Department of Pediatrics | 07/1998 - 2002 |
| Instructor, University of North Carolina at Chapel Hill, School of Pharmacy, Department of Pharmacy Practice | 07/1997 - 06/1998 |
Sponsored Program Funding
| Extramural, Natural History Study of the Development of Type 1 Diabetes, National Institute of Diabetes and Digestive and Kidney Diseases | 07/2013 - Present |
| Extramural, A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination with Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation, Vertex Pharmaceuticals Incorporated | 07/2013 - Present |
| Extramural, A Point Prevalence Study to Evaluate the Prevalence of Antibodies to Selected Porcine Viruses in Patients with Cystic Fibrosis Who Are Receiving Porcine-Derived Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors, Janssen Pharmaceutical, LP | 06/2013 - Present |
| Intramural, Interdisciplinary Quality Improvement Measures in Cystic Fibrosis Patients, University of Mississippi Medical Center Academic Affairs | 04/2013 - Present |
| Extramural, An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With Atypical Hemolytic-Ureemic Syndrome (aHUS Registry), Alexion Pharmaceuticals, Inc | 02/2013 - Present |
| Extramural, A Phase 4, Open-Label, Prospective Study in Patients with Pompe Disease to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale, Genzyme Corporation | 02/2013 - Present |
| Extramural, A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Subjects with Cystic Fibrosis, Gilead Sciences, Inc. | 11/2012 - Present |
| Extramural, A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of ART-123 in Subjects With Severe Sepsis and Coagulopathy, Asahi Kasei Pharma America Corporation | 11/2012 - Present |
| Extramural, A Phase 2 Open-Label, Multicenter, 4-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Relief of Heartburn, in Adolescent Subjects Aged 12 to 17 Years With Symptomatic Non-Erosive Gastroesophageal Reflux Disease, Takeda Global Research & Development Center, Inc | 11/2012 - Present |
| Extramural, A Phase 2 Multicenter, 36-Week Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn, in Adolescent Subjects Aged 12 to 17 Years, Takeda Global Research & Development Center, Inc | 11/2012 - Present |
| Extramural, Gene Discoveries in Subjects with Crohn's Disease of African Descent, Emory University | 09/2012 - Present |
| Extramural, A 12-Week Randomized, Open-Label, Active Comparator Period Followed by a 12-Week Safety Extension Period to Evaluate the Safety and Efficacy of Fesoterodine in Subjects Aged 6 to 16 Years and >25 kg with Symptoms of Detrusor Overactivity Associated with Neurological Condition (Neurogenic Detrusor Overactivity), Pfizer | 06/2012 - Present |
| Intramural, Increasing Interprofessional Interactions Among UMMC Students, University of Mississippi Medical Center Academic Affairs | 04/2012 - Present |
| Extramural, A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors, Cystic Fibrosis Foundation Therapeutics | 04/2012 - Present |
| Extramural, Identification and characterization of CFTR mutations among non-white patients with Cystic Fibrosis to improve the clinical sensitivity of neonatal screening and diagnostic testing, Stanford University Medical Center | 03/2012 - Present |
| Extramural, Developing New Therapies for Cystic Fibrosis: A Role for Pineapples, American Association of Colleges of Pharmacy | 01/2012 - 12/2014 |
| Extramural, Open-label Long Term Safety and Tolerability of an inhaled antibiotic in CF Patients with Chronic Infection Due to Pseudomonas aeruginosa TR02-110, Chiltern International, Inc. | 07/2011 - Present |
| Extramural, Randomized, Active-Controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Arikace in Cystic Fibrosis Patients with Chronic Infection due to Pseudomonas Aeruginosa TR02-108, Chiltern International, Inc. | 07/2011 - Present |
| Extramural, Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy, Safety and Tolerability of an inhaled antibiotic in CF Patients with Chronic Infection Due to Pseudomonas aeruginosa TR02-109, Chiltern International, Inc. | 07/2011 - Present |
| Extramural, A Phase 3, Open-Label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquin) Versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis Patients (MPEX 209), Mpex Pharmaceuticals, Inc. | 06/2011 - 05/2012 |
| Extramural, A Phase 3, multi-center, multinational, randomized, double- blind, placebo-controlled study to evaluate the efficacy and safety of MP- 376 (Levofloxacin Inhalation Solution; Aeroquin) in stable Cystic Fibrosis patients (MPEX 207), Mpex Pharmaceuticals, Inc. | 04/2011 - 06/2012 |
| Extramural, An observational prospective study to access Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age)- Outcomes and Risk Tracking Study (The Report Study), MedImmune Inc. | 07/2010 - Present |
| Extramural, C-09-041: Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years, Alcon Laboratories | 07/2010 - 12/2011 |
| Extramural, Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes, Alcon Laboratories | 07/2010 - 01/2012 |
| Extramural, Closure of Atrial Septal Defects with the AMPLATZER Septal Occluder Post Approval Study (ASD PMS II), AGA Medical , Inc. | 04/2010 - Present |
| Extramural, Phase 3b Randomized, Double-Blind, Placebo-Controlled Two-Part Trial to Assess the Safety and Efficacy of Continuous Aztreonam for Inhalation Solution (AZLI) in Subjects with Cystic Fibrosis (CF) and Chronic Burkholderia Species Infection, Gilead Sciences, Inc | 02/2010 - 09/2010 |
| Extramural, An Open Label Study to Evaluate the Single Dose Pharmacokinetics and Safety of Doripenem in Pediatric Subjects 6 to 17 years of Age, Inclusive, with Cystic Fibrosis, Johnson & Johnson Pharmaceutical, Inc. | 10/2009 - 07/2010 |
| Extramural, A Long-Term, Multi-center, Longitudinal Post-marketing, Observational Registry of Humira (Adalimumab) in Children with Active Juvenile Idiopathic Arthritis (JIA), Abbott Laboratories | 06/2009 - 06/2010 |
| Extramural, A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-Term maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead Formulation in 1-to 11-Year-Old Pediatric Subjects with Endoscopically Proven GERD, Johnson and Johnson Pharmaceutical Research & Development, LLC | 01/2009 - 06/2010 |
| Extramural, The use of formula fortified with docosahexaenoic acid (DHA) in infants with cystic fibrosis, University of Massachusetts | 12/2008 - 10/2009 |
| Extramural, Enhanced Drug Safety Surveillance Project in Juvenile Rheumatoid and Idiopathic Arthritis, Childhood Arthritis and Rheumatology Research Alliance | 11/2008 - 05/2011 |
| Extramural, Magic - Congenital Heart Disease Cardiac Catheterization Data Consortium, John Hopkins Medicine | 08/2008 - 05/2013 |
| Extramural, AMPLATZER® Duct Occluder II Clinical Study, AGA Medical Corp. | 07/2008 - Present |
| Extramural, Health-Related Quality of Life Measure in Pediatric Lupus, UMDNJ RWJ Medical School | 07/2008 - 11/2011 |
| Extramural, Closure of ventricular septal defects with the AMPLATZER® Muscular VSD Occluder – Post Approval Study, AGA Medical Corporation | 04/2008 - Present |
| Extramural, A Phase 3, Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenicity of ProQuad™ Vaccine When Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine to Healthy Toddlers, Novartis Pharmaceuticals | 04/2008 - 12/2010 |
| Extramural, A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Withdrawal Study to Evaluate the Safety and Efficacy of Delayed-Release Rabeprazole in 1-to 11- Month-Old Pediatric Subjects with Symptomatic/Erosive Gastroesophageal Reflux Disease (GERD), Johnson & Johnson Pharmaceuticals | 03/2008 - 11/2011 |
| Extramural, A Randomized, placebo-controlled, multi-center study to evaluate the safety and efficacy of ciprofloxacin (inhaled) compared to placebo in patients with Cystic Fibrosis., Bayer Pharmaceuticals, Inc. | 02/2008 - 03/2011 |
| Extramural, Multidose Safety and Tolerability Study of Lipsomal Amikacin for inhalation (Arikace) in Cystic Fibrosis Patients with Chronic Infections due to Pseudonomas aeruginosa, Transave, Inc. | 01/2008 - 08/2009 |
| Extramural, A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody to Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized with RSV Illness, MedImmune, Inc. | 12/2007 - 11/2008 |
| Extramural, A pharmacokinetic and safety study of single and multiple doses of rabeprazole in pediatric subjects with GERD 1 to 11 years old, inclusive (RABGRD1002), Johnson & Johnson Pharmaceuticals, Inc. | 11/2007 - 01/2010 |
| Extramural, A Pharmacokinetic, pharmacodynamic and safety study of single and multiple doses of rabeprazole in pediatric subjects with GERD 1 to 11 months old, inclusive (1003), Johnson & Johnson Pharmaceuticals, Inc. | 08/2007 - 03/2011 |
| Extramural, A phase III, randomized, double-blind, placebo-controlled clinical study evaluating the efficacy and safety of ALTU-135 treatment in patients with cystic fibrosis-related exocrine pancreatic insufficiency, Altus Pharmaceuticals, Inc. | 08/2007 - 07/2008 |
| Extramural, An open-label clinical study evaluating the long-term safety of ALTU-135 for the treatment of patients with cystic fibrosis-related exocrine pancreatic insufficiency, Altus Pharmaceuticals, Inc. | 06/2007 - 07/2008 |
| Extramural, Bivalirudin (Angiomax®) as a procedural anticoagulant in the pediatric population undergoing intravascular procedures for congenital heart disease, The Medicines Company | 06/2007 - 11/2007 |
| Extramural, A phase 3, randomized, active-controlled, double-blind trial evaluating the safety, tolerability, and immunogenicity of 3 lots of 13-valent pneumococcal conjugate vaccine in healthy infants given with routine pediatric vaccinations in the United States, Wyeth Pharmaceuticals | 05/2007 - 12/2010 |
| Extramural, A 7-day, randomized, double-masked, parallel-group, multicenter study to evaluate the safety and efficacy of topical gatifloxacin 0.3% ophthalmic solution compared with topical moxifloxacin 0.5% ophthalmic solution for the treatment of presumed bacterial conjunctivitis, Allergan | 05/2007 - 12/2008 |
| Intramural, Serum procalcitonin levels and their correlation with infection in the pediatric sickle cell population, Department of Pediatrics | 01/2007 - Present |
| Extramural, A multicenter, randomized, double-blind, placebo-controlled trial of Pulmozyme® withdrawal on exercise tolerance in cystic fibrosis subjects with severe lung disease., Genentech, Inc. | 01/2007 - 01/2009 |
| Extramural, Clinical Research Facilitation Award Program, Cystic Fibrosis Foundation Therapeutics, In. | 01/2007 - 12/2008 |
| Intramural, Anatomical Models for Use in Problem-Based Learning Format, Univ. of Miss. Provost's Partners Grants Program | 01/2007 - 01/2008 |
| Extramural, Safety and Efficacy Evaluation of HalfLytely® Solution and Bisacodyl Tablets vs. NuLYTELY ® in the Pediatric Population, Braintree Laboratories, Inc. | 01/2007 - 05/2007 |
| Intramural, Pharmacokinetic Evaluation Utilizing Microdialysis Technique, Univ. of Miss. Provost's Associates Grant Program | 12/2006 - 12/2007 |
| Extramural, A phase 3, double-blind, multicenter, multinational, randomized, placebo-controlled trial evaluating aztreonam lysinate for inhalation in cystic fibrosis patients with pulmonary P. aeruginosa, Gilead Sciences | 12/2006 - 05/2007 |
| Extramural, A multicenter, randomized, open-label, single and multiple-dose study of the pharmacokinetics and safety of two dose levels of pantoprazole sodium tablets in adolescents aged 12 through 16 years with a clinical diagnosis of GERD (337), Wyeth Pharmaceuticals | 11/2006 - 11/2007 |
| Extramural, A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study of the Efficacy and Safety of Pantoprazole Sodium Enteric-Coated Granules in Infants 1 Through 11 Months with Symptomatic GERD (329), Wyeth Pharmaceuticals | 09/2006 - 03/2008 |
| Intramural, Impact of Acute vs Chronic Illness on Spiritual Well-Being, UMC Department of Pediatrics | 09/2006 - 09/2007 |
| Extramural, An Epidemiological Study to Evaluate the Seasonality of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections (LRI) or Apnea in Infants in the Emergency Department, MedImmune, Inc. | 05/2006 - 07/2008 |
| Extramural, A Multicenter, Randomized, Double-Blind Study of the Safety, Clinical Outcomes, and Tolerability of Multiple Doses of Pantoprazole Sodium Enteric-Coated Spheroids in Children Ages 1 to 5 Years, With Endoscopically Proven Symptomatic GERD (328), Wyeth Pharmaceuticals | 02/2006 - 08/2008 |
| Extramural, A Multicenter, Open Label Safety study of 2 Doses of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged 1 Through 11 Months With Presumed GERD (335), Wyeth Pharmaceuticals | 11/2005 - 11/2007 |
| Extramural, A Multicenter, Randomized, Open Label, Single and Multiple Dose Study of the Pharmacokinetics and Pharmacodynamics of 2 Dose Levels of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged 1 Through 11 Months With Presumed GERD (333), Wyeth Pharmaceuticals | 08/2005 - 04/2008 |
| Extramural, A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of Pantoprazole Sodium in Children Aged 1 Through 11 Years with Endoscopically Proven GERD (334), Wyeth Pharmaceuticals | 06/2005 - 03/2008 |
| Extramural, The EPIC Clinical Study, CF Therapeutics Development Network | 05/2005 - 06/2009 |
| Extramural, Comparison Between Surgical vs Balloon Angioplasty vs Intravascular Stent Placement for Recurrent Or Native Coarctation Of The Aorta, Wayne State University | 01/2005 - Present |
| Extramural, A Phase III, Randomized, Double-blind, Multi-center Clinical Trial Comparing the Safety and Efficacy of Veronate Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500-1250 g), Inhibitex, Inc. | 01/2005 - 01/2006 |
| Extramural, The EPIC Observational Study, Cystic Fibrosis Therapeutics Development Network | 11/2004 - Present |
| Extramural, PEDS 1: A Randomized, Double-blind, Placebo Withdrawal, Parallel Group, Dose-response study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children, Pfizer | 11/2004 - 11/2007 |
| Extramural, A Phase III, Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety and Clinical Outcome of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients 1 to 11 Years of Age, Inclusive, AstraZeneca | 10/2004 - 11/2005 |
| Extramural, A Phase 1, Single- and Repeated Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Infants with Clinically-Evident Gastroesophageal Reflux Disease, Tap Pharmaceuticals Products, Inc. | 09/2004 - 11/2005 |
| Extramural, A Study of the Pharmacokinetics, Safety, and Tolerability of Intravenous Doses of Pantoprazole in Hospitalized Pediatric Patients, Wyeth Pharmaceuticals | 09/2004 - 11/2005 |
| Extramural, A Phase 1, Single- and Repeated Dose, Randomized, Open-Label, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Lansoprazole in Neonates with Clinically-Evident Gastroesophageal Reflux Disease, Tap Pharmaceutical Products, Inc. | 09/2004 - 10/2005 |
| Extramural, Multi-Center, Randomized, Single-Blind, Vancomycin-Controlled, Dose-Range Finding Study of Nitazoxanide in the Treatment of Clostridium Difficile colitis in Pediatric Patients, Romark Institute for Medical Research | 08/2004 - 07/2005 |
| Extramural, Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study of Oral TheraCLEC-Total in Cystic Fibrosis Subjects with Exocrine Pancreatic Insufficiency, Altus Biologics, Inc. | 07/2004 - 06/2005 |
| Extramural, A Multicenter, Multinational, Open-Label Study of the Efficacy, Safety and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6 to < 17 Years of Age, AstraZeneca | 05/2004 - 04/2006 |
| Extramural, A Dose-Ranging and Safety Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 6 to < 17 Years of Age: A 4-Week, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study, AstraZeneca | 05/2004 - 11/2005 |
| Extramural, A Phase III, Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric and Adolescent Patients 12 to 17 Years of Age, Inclusive, AstraZeneca | 02/2004 - 07/2005 |
| Extramural, Genetic Modifiers in Cystic Fibrosis Liver Disease, University of North Carolina Hospitals and Clinic and CF Foundation | 11/2003 - Present |
| Extramural, Post Market Surveillance Plan for the Amplatzer Duct Occluder, AGA Medical, Inc. | 10/2003 - 03/2009 |
| Extramural, A double-blind, randomized, multicenter stratified study to assess the safety of an intravenous staphylococcus aureus immune globulin (human) [Altastaph] in low-birth-weight neonates, Nabi Biopharmaceuticals | 06/2003 - 12/2004 |
| Intramural, Pharmacokinetics of Pentoxifylline and Its Major Metabolites in the Rabbit After Intranasal, Intratracheal, and Intravenous Administration, Pediatric Departmental Research Grants | 04/2003 - 05/2004 |
| Extramural, Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis, Eli Lilly and Co | 03/2003 - 07/2005 |
| Intramural, Pentoxifylline Pharmacokinetics in the Rabbit after Intranasal, Intratracheal and Intravenous Administration, UM Faculty Research Program | 03/2003 - 05/2004 |
| Extramural, Newly Designed Curved Balloon for Use in Stent Placement in Pediatric Patients, NuMed, Inc. | 03/2003 - 03/2004 |
| Extramural, Genetic Modifiers in Cystic Fibrosis: Twin/Sibling Study, John Hopkins Unversity | 12/2002 - 12/2012 |
| Extramural, A Multi-Center, Randomized, Double-Blind Study of the Safety, Tolerability and Clinical Outcomes of Two Doses (20 and 40 mg) of Oral Pantoprazole in Children (12-16 years old) with Symptomatic GERD, Wyeth Pharmaceutical, Inc. | 10/2002 - 10/2004 |
| Extramural, A Multi-Center, Randomized, Double-Blind Study of the Safety, Tolerability and Clinical Outcomes of Multiple Doses (10, 20, and 40 mg) of Oral Pantoprazole in Children (5-11 years old) with Symptomatic GERD, Wyeth Pharmaceuticals | 10/2002 - 03/2004 |
| Extramural, Multi-Site Monitoring Project for Antimicrobial Resistance among Helicobacter pylori Isolates in the United States, Centers for Disease Control and Prevention | 08/2002 - 05/2006 |
| Extramural, Genetic Modifiers in Cystic Fibrosis Lung Disease, University of North Carolina Hospitals and Clinics | 07/2002 - Present |
| Extramural, ASO Post Market Surveillance Protocol, AGA Medical, Inc. | 07/2002 - 07/2007 |
| Extramural, The Effects of Inhaled Fluticasone on Inflammatory Mediators in Neonates at Risk for Chronic Lung Disease., GlaxoSmithKline | 04/2001 - 04/2003 |
| Extramural, The Effects of Inhaled Fluticasone on Inflammatory Mediators in Neonates at Risk for Chronic Lung Disease., The American Association of Colleges of Pharmacy | 04/2001 - 04/2003 |
| Extramural, Closure of Ventricular Septal Defects with the Amplatzer VSD Occluder, AGA Medical, Inc. | 01/2001 - 05/2007 |
| Extramural, Linezolid: Single-dose Pharmacokinetic Assessment in Pediatric Patients, Pharmacia & Upjohn | 01/2001 - 12/2002 |
| Intramural, Bioavailability of a New Oral Nifedipine Suspension, NIH PPRU Network Grant | 06/2000 - 07/2002 |
Publications
Journal Article | |
| Adcock KG, Hogan SM, Elic OU, Mills KL Do Illustrations Improve Children's Comprehension of Assent Documents? J Pediatr Pharmacol Ther. 2013;17(3):228-235 | 2013 |
| Mayer-Hamblett N, Kronmal RA, Gibson RL, Rosenfeld M, Retsch-Bogart G, Treggiari MM, Burns JL, Kahn U, (KG Adcock, Member) Initial Pseudomonas aeruginosa Treatment Failure is Associated with Exacerbations in Cystic Fibrosis Pediatric Pulmonology 2012:47 (2): 125-134 | 2012 |
| Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, Khan U, Kulich M, Kronmal R, Williams J, Hiatt P, Gibson RL, Spencer T, Orenstein D, Chatfield BA, Froh DK, Burns JL, Rosenfeld M, Ramsey BW for the EPIC Investigators (KG Adcock, Member) Comparative Efficacy and Safety of Four Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children with Cystic Fibrosis. Archives of Pediatrics and Adolescent Medicine. Pediatr Adolesc Med. 2011;165:847-56. | 2011 |
| Tammara BK, Sullivan JE, Adcock KG, Springer MA, Kierkus J, Giblin J, Rath N, Meng X, Maguire MK, Comer GM, Ward RM. Multicenter, Randomized, Open-Label Pharmacokinetic Studies of Two Dose Levels of Pantoprazole Granules in Children Aged 1 Month Through <6 Years With Gastroesophageal Reflux Disease. Clin Pharmacokinet. 2011;50(8):541-50 | 2011 |
| Ward RM, Kearns GL, Tammara B, Bishop P, O'Gorman MA, James LP, Katz MH, Maguire MK, Rath N, Meng X, Comer GM (KG Adcock, Study Team Member). A Multicenter, Randomized, Open-Label, Pharmacokinetics and Safety Study of Pantoprazole Tablets in Children and Adolescents Aged 6 Through 16 Years With Gastroesophageal Reflux Disease J Clin Pharmacol. 2011;51(6):876-87 | 2011 |
| Baker R, Tsou VM, Tung J, Baker SS, Li H, Wang W, Rath N, Maguire MK, Comer GM (KG Adcock Study Team Member). Clinical results from a randomized, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis Clin Pediatr. 2010 Sep;49(9):852-65 | 2010 |
| Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL; EPIC Study Group Participating Clinical Sites (KG Adcock, Member). Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatr Pulmonol. 2010 Sep;45(9):934-44. | 2010 |
| LN Moorthy, MGE Peterson, MJ Baratelli, AL Hassett, TJA Lehman the International SMILEY© Collaborative Group (KG Adcock, member). Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort. Lupus. 2010 Jan;19(1):83 – 88 | 2010 |
| Barlett JR, Friedman KJ, Ling SC, Pace RG; Gene Modifier Study Group (KG Adcock, member) Genetic Modifiers of Liver Disease in Cystic Fibrosis JAMA 2009 Sept;302(10):1076-1083 | 2009 |
| Treggiari MM, Rosenfeld M, Mayer-Hablett N, Retcsch-Bogart G, Gibson RL, Williams J, Emerson J, Kronmal RA, Ramsey BW, EPIC Study Group (KG Adcock, member). Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study. Contemporary Clinical Trials. 2009 May;30(3):256-268 | 2009 |
| Kearns GL, Blumer J, Schexnayder S, James LP, Adcock KG, Reed MD, Daniel JF, Gaedigk A, Paul J Single-dose pharmacokinetics of oral and intravenous pantoprazole in children and adolescents. J Clin Pharmacol. 2008;48(11):1356-65. | 2008 |
| Adcock KG, Hogan SM Extrinsic Iron Staining in Infant Teeth from Iron-Fortified Formula and Rice Cereal J Pediatr Pharmacol Ther. 2008;13(3):162-165. | 2008 |
| Hogan S, Adcock K. Cervical Cancer Prevention: How Mississippi Pharmacists Can Play a Role Mississippi Pharmacist. Spring 2008; 11-13 | 2008 |
| Adcock KG, Kyle PB, Deaton JS, Olivier JH, Hogan SM Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits. Pharmacotherapy. 2007;27(2):200-206. | 2007 |
| Adcock KG, Ostrenga J, Hogan S, Olivier J. Evaluating Comprehension by children of clinical research assent documents. Monitor 2007;21(2):61-64. | 2007 |
| Tsou VM. Baker R. Book L. Hammo AH. Soffer EF. Wang W. Comer GM. 326 Study Group (KG Adcock, Member). Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD). Clinical Pediatrics. 2006;45(8):741-749. | 2006 |
| Hogan S, Adcock KG. Weekly rotation of facilitators to improve assessment of group participation in a problem-based learning curriculum. AJPE.2006;70(6):127. | 2006 |
| Benjamin DK. Schelonka R. White R. Holley HP. Bifano E. Cummings J. Adcock K. Kaufman D. Puppala B. Riedel P. Hall B. White J. Cotton CM. S. aureus prevention investigators. A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin. Journal of Perinatology. 2006;26(5):290-295. | 2006 |
| Tolia V. Bishop PR. Tsou VM. Gremse D. Soffer EF. Comer GM. Members of the 322 Study Group (KG Adcock, Member). Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. Journal of Pediatric Gastroenterology & Nutrition. 2006;42(4):384-391. | 2006 |
| Adcock KG. Prescribing principles for children: foundation of a rational approach Advance for Nurse Practitioners. 2006;14(3):30-35. | 2006 |
| Drumm ML. Konstan MW. Schluchter MD. Handler A. Pace R. Zou F. Zariwala M. Fargo D. Xu A. Dunn JM. Darrah RJ. Dorfman R. Sandford AJ. Corey M. Zielenski J. Durie P. Goddard K. Yankaskas JR. Wright FA. Knowles MR. Gene Modifier Study Group (KG Adcock, Member). Genetic modifiers of lung disease in cystic fibrosis. NEJM. 2005;353(14):1443-1453. | 2005 |
| Kyle PB, Adcock KG, Kramer RE, and Baker RC Use of liquid chromatography tandem mass spectrometry for the analysis of pentoxifylline and lisofylline in plasma Biomedical Chromatography. 2005;19(3):231 236. | 2005 |
| Hedberg CL, Adcock K, Martin J, Loggins J, Baier RJ. The Tumor Necrosis Factor- α (TNF- α)-308 Polymorphism is Associated with Increased Sepsis Mortality in Ventilated Very Low Birth Weight (VLBW) Infants. Pediatric Infectious Disease Journal 2004; 23(5):424-428. | 2004 |
| Adcock KG, Martin J, Loggins J, Kruger TE, Baier RJ. Elevated PDGF-BB concentrations in premature neonates who develop chronic lung disease. BioMed Central Pediatrics 2004;4:10. | 2004 |
| Ebeid MR, Adcock KG, Robert B, Villnave D, Tower AG. A new Eb curved balloon to curve stents across the aortic arch. Catheterization and Cardiovascular Interventions. 2004: 63(1):120 | 2004 |
| Adcock KG, Hedberg C, Loggins J, Kruger TE, Baier RJ. TNFα -308, MCP-1 -2518 and TGFβ1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes and Immunity 2003;4(6):420-426 | 2003 |
| Kearns GL. Robinson PK. Wilson JT. Wilson-Costello D. Knight GR. Ward RM. van den Anker JN. Pediatric Pharmacology Research Unit Network (KG Adcock, Member). Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny Clinical Pharmacology & Therapeutics 2003:74(4):312-325. | 2003 |
| Maples HD. James LP. Stowe CD. Jones DP. Hak EB. Blumer JL. Vogt B. Wilson JT. Kearns GL. Wells TG. Network of Pediatric Pharmacology Research Units (KG Adcock, Member). Famotidine disposition in children and adolescents with chronic renal insufficiency Journal of Clinical Pharmacology. 2003:43(1):7-14. | 2003 |
| Adcock KG, Wilson JT. Nifedipine Illustrates the Pediatric Labeling Dilemma for Off-Patent Drugs. Pediatrics 2002;109(2):319-321 | 2002 |
| Abdel-Rahman SM. Leeder JS. Wilson JT. Gaedigk A. Gotschall RR. Medve R. Liao S. Spielberg SP. Kearns GL. Pediatric Pharmacology Research Unit Network (KG Adcock, Member). Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation. Journal of Clinical Pharmacology. 2002;42(1):24-29. | 2002 |
| Sakarcan A, Tenney F, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR. The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents. Journal of Clinical Pharmacology. 2001;41:742-749. | 2001 |
| Adcock KG, Akins RL, Farrington EA. Evaluation of Empiric Vancomycin Use in Pediatric Patients with Fever and Neutropenia. Pharmacotherapy 1999;19(11):1315-1320. | 1999 |
| Adcock KG, Brock T, Adcock TT, Farrington EA. Asthma Knowledge of Elementary School Teachers: Impact on Care. Journal of Pediatric Pharmacy Practice 1997;2(6):350-352 | 1997 |
| Adcock KG, Farrington EA. Y-Site Drug Compatibility with TPN. Drug Topics 1996;140(10):76-85. | 1996 |
| Busby SM, Parks BR, Griffin K Asthma Management Primer (Continuing Education). Drug Topics 1996;140(10):76-85. | 1996 |
Review Article | |
| Adcock KG, MacElroy D, Wolford E, Farrington EA Pemoline Hepatotoxicity: Review of Cases and Outcomes Annals of Pharmacotherapy 1998;32(4):422-424. | 1998 |
Abstracts | |
| Turner A, Adcock KG. An Assessment of Vitamin D Supplementation and Its Effectiveness in Patients with Cystic Fibrosis Pharmacotherapy, 34: e74–e115. doi: 10.1002/phar.1449. | 2014 |
| Adcock KG, Chaudary N, Majure JM A pilot study on the perceptions and use of complementary and alternative medicine in cystic fibrosis patients and their parents Pediatric Pulmonology. 2013;48(s36):436. | 2013 |
| Hogan SM, Adcock KG, Mathur S. Influence of home asthma maintenance therapy on frequency of pediatric hospital admissions. Pharmacotherapy. 2008;28(10):165e abstract 170. | 2013 |
| Adcock KG, McClendon KS, Hogan SM, Bell AM, Sherman JJ. Targeted learning based on formative assessments of SOAP notes. American Journal of Pharmaceutical Education. 2013;77(5):109. | 2013 |
| Adcock KG, Harrell K, Hogan SM, Riche DM, Stover KR, Theilman GD, Ross LA, Wilson MC, Allen DD. Implementation, Assessment, and Refinement of a Problem-Based Learning Model at the University of Mississippi. American Journal of Pharmaceutical Education. 2013;77(5):109. | 2013 |
| McClendon KS, Hogan SM, Adcock KG, Pitcock JJ, Riche DM. Alternative treatment plan assignments: increasing student knowledge and skills. American Journal of Pharmaceutical Education. 2013;77(5):109. | 2013 |
| Bell AM, McClendon KS, Hogan SM, Adcock KG, Riche DM, Ellis AW. Pharmacy Practice Pathway: Results of Implementation of a Research Program in PharmD Courses. American Journal of Pharmaceutical Education. 2013;77(5):109 | 2013 |
| Adcock KG, Bell AM, Hogan SM, Riche DM, McClendon KS A novel spin on the traditional SOAP note. American Journal of Pharmaceutical Education. American Journal of Pharmaceutical Education. 2013;77(5):109. | 2013 |
| Hogan SM, Adcock KG, Ellis AW, Riche DM, McClendon KS. Implementation of a pharmacy practice pathway at the University of Mississippi. American Journal of Pharmaceutical Education. 2011;75(5):105. | 2012 |
| Adcock KG, Bloodworth LS, Harrell K, Sherman JJ, Strum, MW, Theilman GD, Ross LA, Wilson MC, Allen DD. Interprofessionalism across the University of Mississippi school of pharmacy tripartite mission. American Journal of Pharmaceutical Education. 2012;76(5):99. | 2012 |
| Bentley JP, Adcock KG, Dikun JA, Athavale AS. Do pharmacy students read exam instructions? American Journal of Pharmaceutical Education. 2012;76(5):99. | 2012 |
| Tammara B, Adcock K, Kearns GL, Ward RM, Giblin JM, Shaheen C, Meng X, Maguire MK, Comer GM. Pharmacokinetics of Two Dose Levels of Pantoprazole Sodium Granules and Tablets in Children Aged 1 Through 11 Years with Endoscopically Proven GERD. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Abstract 2 | 2008 |
| Tammara B, Adcock K, Kearns GL, Ward RM, Giblin JM, Shaheen C, Meng X, Maguire MK, Comer GM. Pharmacokinetics of Two Dose Levels of Pantoprazole Sodium Granules and Tablets in Children Aged 1 Through 11 Years with Endoscopically Proven GERD. American College of Gastroenterology. Abstract P363 | 2008 |
| Benson B, Laird L, Adcock K, Hogan S, Crout J, Dillard B. Screening for pediatric hypertension in the emergency department. Journal of Pediatric Pharmacology and Therapeutics. 2008;13(3)186. | 2008 |
| Hogan SM, Adcock KG, Mathur S. Influence of home asthma maintenance therapy on frequency of pediatric hospital admissions. Journal of Pediatric Pharmacology and Therapeutics. 2008;13(3)185. | 2008 |
| Springer M, Atkinson S, Raanan M, Sutkowski-Markmann D. Symptom relief results in pharmacodynamic/pharmacokinetic studies of lansoprazole in infants and neonates with clinically evident gastroesophageal reflux disease (GERD) ]. J Pediatr Gastroenterol Nutr. 2006;43(4):E18-E19. | 2006 |
| Zhang W. Kukulka MJ, Witt G, Sutkowski-Markmann D, North J, Atkinson S. Substantial differences in lansoprazole pharmacokinetics between older and younger infants and neonates Gastroenterology. 2006;130(4 Suppl 2):A-4.21. | 2006 |
| Springer M, Zhang W, Atkinson S, North J, Raanan M, Witt G. Pharmacokinetic and pharmacodynamic profiles and symptom relief in infants with clinically evident GERD treated with lansoprazole ]. Ped Research. 2006;4811.49. | 2006 |
| Adcock KG, Kyle PB, Deaton JS, Olivier J. Pentoxifylline pharmacokinetics following two novel delivery techniques Pharmacotherapy 2004;24(10):1453 abstract 219. | 2004 |
| Adcock K, Martin J, Baier RJ The Effect of Inhaled Steroid Therapy on Tracheal Aspirate (TA) Cytokine Concentrations in Very Low Birth Weight (VLBW) Infants at Risk for Chronic Lung Disease. Pharmacotherapy 2003;23(10):S143 abstract 333. | 2003 |
| Adcock K, Loggins J, Kruger TE, Baier RJ The Effect of Inhaled Fluticasone (Flovent®) on Tracheal Aspirate (TA) Concentrations of Cytokines in Very Low Birth Weight (VLBW) Infants. Journal of Investigative Medicine 2003; 51(1):S211 abstract 69. | 2003 |
| Baier RJ, Adcock K, Hedberg CL, Loggins J, Kruger TE The TNF α -308, MCP-1-2518 and TGF1+915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight (VLBW) infants. Pediatric Research 2003;53:411A. | 2003 |
| Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ. The Tumor Necrosis Factor α (TNF-α)-308 G/A Polymorphism is Associated with Increased Sepsis Mortality in Ventilated Very Low Birth Weight (VLBW) Infants. Journal of Investigative Medicine 2003; 51(1):S211 abstract 68. | 2003 |
| Adcock K, Loggins J, Kruger TE, Baier RJ Platelet derived growth factor BB is increased in infants who develop bronchopulmonary dysplasia. Journal of Investigative Medicine 2002;50(1):139S abstract 772. | 2002 |
| Adcock KG, Martin JG, Rowell JP, Wilson JT Predose vital signs predict the effect of nifedipine on blood pressure and heart rate in normotensive young adults. Journal of Investigative Medicine 2002;50(1):136S abstract 739. | 2002 |
| Adcock K, Johnson C, Dust J, Loggins J, Baier RJ, Kruger TE Cytokine genotyping using tracheal aspirates in ventilated infants. Journal of Investigative Medicine 2002;50(1):99S abstract 66. | 2002 |
| Adcock KG, Rowell J, Davis TO, Johnson V, Chen JR, Wilson JT Pharmacokinetics of a new nifedipine suspension in young adults. Pharmacotherapy 2001;21(10):1282 abstract 176. | 2001 |
| Leeder JS, Gotschall R, Gaedigk A, Adcock K, Wilson JT, Kearns GL. Maturation of Cytochrome P450 (CYP) 2D6 and 3A4 Activities in vivo in the First Year of Life. Proceedings of the 13th International Symposium on Microsomes and Drug Oxidations, Stresa, Italy, July 10-14, 2000. | 2000 |
| Leeder JS, Adcock K, Gaedigk A, Gotschall R, Wilson JT, Kearns GL Acquisition of CYP2D6 and CYP3A4 Activities in the First Year of Life. Clin Pharmacol Ther 2000;67:168 abstract OIII-B-3. | 2000 |
| Leeder JS, Adcock K, Gaedigk A, Gotschall R, Wilson JT, Kearns GL. Delayed Maturation of Cytochrome P450 3A (CYP3A) Activity in vivo in the First Year of Life. Proceedings of the PAS/SPR Year 2000 Joint Meeting, abstract 2788, 2000. | 2000 |
| Sakarcan A, Tenney F, Wilson JT, Stewart JJ, Adcock KG, Wells TG, Vachharajani NN, Hadjilambris OW, Slugg P, Ford NF, Marino MR. The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents. J Am Soc Nephrol 2000;11:354A abstract A1851. | 2000 |
| Leeder, J.S., Gotschall, R.R., Gaedigk, A., Adcock, K., Wilson, J.T. and Kearns, G.L Acquisition of functional CYP2D6 and CYP3A4 activities in vivo in the first year of life Drug Metab. Rev. 2000;32(Suppl 2):281 abstract #289. | 2000 |
Book Chapter | |
| Adcock KG, Stewart J. Patient 7: A twelve-year-old girl with a mild elevation in blood pressure and frequent headaches (Pediatric Obesity). In: Jones DW, Wofford MR, King DS, editors. Hypertension Pearls. Pennsylvania: Hanley & Belfus, Inc.; 2004. p. 21-23. | 2004 |
| Kearns GL, Adcock KG, Wilson JT. Drug Therapy in Pediatric Patients. In: Van Boxtel C, Santoso B, Edwards I, editors. Drug Therapy in Pediatric Patients; Drug Benefits and Risks, International Textbook of Clinical Pharmacology New York : J. Wiley; 2001. p.159-174. | 2001 |
Electronic Publications | |
| Fouquier K, Gordon C, Adcock KG, Estes F, Jones M, Croff-Poole L. The Introverted Leader: Building on Your Quiet Strength Video. UMMC Leadership Development Program. July 2012. | 2012 |
| Bell A, Adcock KG Redneck Rollercoaster IPE Video. Increasing Interprofessional Interactions Among UMMC Students. University of Mississippi Medical Center Academic Affairs. May 2012. | 2012 |
| Adcock KG. Pediatric Rotation Website | 2008 |
| Adcock KG Pediatric Student Blog. | |
Presentations
| National and International Invited Seminars/Lectures, Curricular Approaches to Active Learning, American Association of Colleges of Pharmacy, Grapevine, Texas | 07/2104 |
| Poster Presentation, An Assessment of Vitamin D Supplementation and Its Effectiveness in Patients with Cystic Fibrosis, American Society of Health-System Pharmacists, Orlando, Florida | 12/2014 |
| Poster Presentation, Adjunct and Part-Time Pharmacy Practice Faculty Promotion: Current Practices and Future Models, American Association of Colleges of Pharmacy Annual Meeting, Grapevine, Texas | 07/2014 |
| Poster Presentation, An Assessment of Vitamin D Supplementation and Its Effectiveness in Patients With Cystic Fibrosis, American College of Clinical Pharmacy, Virtual Poster Symposium | 05/2014 |
| Poster Presentation, A Pilot Study on the Perceptions and Use of Complementary and Alternative Medicine in Cystic Fibrosis Patients and Their Parents., 2013 North American CF Conference, Salt Lake City, UT | 10/2013 |
| Poster Presentation, A Novel Spin on the Traditional SOAP Note., American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL | 07/2013 |
| Poster Presentation, Alternative Treatment Plan Assignments: Increasing Student Knowledge and Skills., American Association of Colleges of Pharmacy Annual Meeting., Chicago, IL | 07/2013 |
| Poster Presentation, Implementation, Assessment, and Refinement of a Problem-Based Learning Model at the University of Mississippi, American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL | 07/2013 |
| Poster Presentation, Targeted Learning Based on Formative Assessments of SOAP Notes., American Association of Colleges of Pharmacy Annual Meeting., Chicago, IL | 07/2013 |
| Poster Presentation, Pharmacy Practice Pathway: Results of Implementation of a Research Program in PharmD Courses., American Association of Colleges of Pharmacy Annual Meeting., Chicago, IL | 07/2013 |
| Poster Presentation, Interprofessionalism across the University of Mississippi School of Pharmacy tripartite mission, American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, FL | 07/2013 |
| Poster Presentation, Parent Perceptions about Children Participating in Cystic Fibrosis Research., ASHP Midyear Meeting, Las Vegas, NV | 12/2012 |
| Poster Presentation, Compliance Rates of Medication in a Retail Pharmacy., ASHP Midyear Meeting., Las Vegas, NV | 12/2012 |
| Poster Presentation, Knowledge, Interest, and Barriers for Pharmacist-Provided Medication Therapy Management Services., University of Mississippi School of Pharmacy Research Day., Oxford, MS | 10/2012 |
| Poster Presentation, Do Pharmacy Students Read Exam Instructions?, American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, Florida | 07/2012 |
| Poster Presentation, Pilot study of factors leading to asthma exacerbations and hospitalizations in a pediatric population, Mississippi Society of Health-System Pharmacists Annual Meeting., Jackson, MS | 07/2012 |
| Poster Presentation, Parent Perceptions about Children Participating in Cystic Fibrosis Research., Mississippi Society of Health-System Pharmacists Annual Meeting, Jackson, MS | 07/2012 |
| Poster Presentation, Readability Score of Informed Consent Documents: Are All Sections Equal?, PRIM&R Annual Conference, Baltimore, Maryland | 12/2011 |
| Poster Presentation, Implementation of a Pharmacy Practice Pathway at the University of Mississippi, 2011 AACP Annual Meeting, San Antonio, Texas | 07/2011 |
| Poster Presentation, Children’s Comprehension of Clinical Research Assent Documents., 20th Annual Meeting, Pediatric Pharmacy Advocacy Group, Memphis, Tennessee | 03/2011 |
| National and International Invited Seminars/Lectures, Building Professional Competencies through Student-Led Scholarship: Capstone Experiences at Four Institutions, 2011 AACP Annual Meeting, San Antonio, Texas | 2011 |
| State/Local Invited Seminars/Lectures, Clinical Research: Nuts and Bolts of Regulatory Compliance., Dept. of Emergency Medicine- UMC, Jackson, MS | 2011 |
| State/Local Invited Seminars/Lectures, Pharmacy is Phundamental, American Academy of Pediatrics Fall Meeting, Jackson, MS | 2011 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY3 Orientation, University of Mississippi Medical Center | 08/2010 |
| Poster Presentation, The Relationship between Quantitative-based Admissions Criteria and Performance in a Drug Literature Evaluation Course., 2010 Annual Meeting and Seminars, American Association of Colleges of Pharmacy, Seattle, Washington | 07/2010 |
| Poster Presentation, Assessment of an Integrated Drug Literature Evaluation Course., 2010 Annual Meeting and Seminars, American Association of Colleges of Pharmacy, Seattle, Washington | 07/2010 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY2 Jackson Visit, University of Mississippi Medical Center | 04/2010 |
| Poster Presentation, Children’s Comprehension of Clinical Research Assent Documents 2010 (2nd Place Award 2010 Research Day Poster Competition), Proceedings of the 6th Annual Department of Medicine Research Day, University of Mississippi Medical Center | 04/2010 |
| State/Local Invited Seminars/Lectures, “Nuts and Bolts of Establishing a Clinical Research Program.”, Anesthesiology Conference, University of Mississippi Medical Center | 2010 |
| National and International Invited Seminars/Lectures, The Teach Back Method, Magi Clinical Research Conference – 2009, East. Miami, Florida | 05/2009 |
| National and International Invited Seminars/Lectures, Writing Informed Consent Forms: Pediatric Assent, Magi Clinical Research Conference – 2009, East. Miami, Florida | 05/2009 |
| Poster Presentation, Screening for Pediatric Hypertension in the Emergency Department, Proceedings of the 5th Annual Department of Medicine Research Day, University of Mississippi Medical Center | 04/2009 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY2 Jackson Visit, University of Mississippi Medical Center | 2009 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY3 Orientation, University of Mississippi Medical Center | 2009 |
| Poster Presentation, Pharmacokinetics of 2 Dose Levels of Pantoprazole Granules and Tablets in Children 1 Through 11 Years With Endoscopically-Proven GERD., North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), San Diego, California | 11/2008 |
| Poster Presentation, Influence of Home Asthma Maintenance Therapy on Frequency of Pediatric Hospital Admissions, 2008 Annual Meeting, American College of Clinical Pharmacy, Louisville, Kentucky | 10/2008 |
| Poster Presentation, Influence of Home Asthma Maintenance Therapy on Frequency of Pediatric Hospital Admissions., 17th Annual Meeting, Pediatric Pharmacy Advocacy Group, Baltimore, Maryland | 10/2008 |
| Poster Presentation, Pharmacokinetics of 2 Dose Levels of Pantoprazole Granules and Tablets in Children 1 Through 11 Years With Endoscopically-Proven GERD, American College of Gastroenterology, Orlando, Florida | 10/2008 |
| Poster Presentation, Screening for Pediatric Hypertension in the Emergency Department, 17th Annual Meeting, Pediatric Pharmacuy Advocacy Group, Baltimore, Maryland | 2008 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY3 Orientation, University of Mississippi | 2008 |
| Poster Presentation, The Influence of Assent Document Format on Children’s Comprehension, Spring Practice and Research Forum, American College of Clinical Pharmacy, Memphis, Tennessee | 04/2007 |
| State/Local Invited Seminars/Lectures, “Pediatric Clinical Research Program.”, University of Mississippi Medical Center Hospital Administration, University of Mississippi Medical Center | 2007 |
| State/Local Invited Seminars/Lectures, “Anatomical Models.”, PY3 Orientation, University of Mississippi | 2007 |
| State/Local Invited Seminars/Lectures, “The Electronic IRB.”, Pediatric Faculty Meeting, University of Mississippi Medical Center | 2007 |
| State/Local Invited Seminars/Lectures, “Informational Skills in Pharmacy Practice Overview.”, PY3 Orientation, University of Mississippi | 2007 |
| State/Local Invited Seminars/Lectures, “Therapeutic Drug Monitoring.”, Pediatric Case Conference, University of Mississippi Medical Center | 2006 |
| State/Local Invited Seminars/Lectures, “Group Process (PRCT 557, 560, 563, 569 Pharmaceutical Care Courses)”, PY3 Orientation, University of Mississippi | 2006 |
| State/Local Invited Seminars/Lectures, “Clinical Research.”, School of Pharmacy Faculty Retreat, University of Mississippi | 2006 |
| State/Local Invited Seminars/Lectures, “Clinical Research.”, Pediatric Faculty Retreat, Unversity of Mississippi Medical | 2006 |
| Poster Presentation, Pharmacokinetics of Intravenous Pantoprazole in Children Ages 1 to 16 Years, 70th American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course., Honolulu, Hawaii | 10/2005 |
| State/Local Invited Seminars/Lectures, “Pentoxifylline Pharmacokinetics Following Two Novel Delivery Techniques.”, Pediatric Research Meeting, University of Mississippi Medical Center | 2005 |
| Poster Presentation, Symptom Improvement in Children with Non-Erosive GERD with Biopsy Evidence of Esophagitis Treated with Pantoprazole, 69th American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course, Orlando, Florida | 10/2004 |
| Poster Presentation, Pentoxifylline pharmacokinetics following two novel delivery techniques., American College of Clinical Pharmacy, Dallas, Texas | 10/2004 |
| Regional Invited Seminars/Lectures, The Tumor Necrosis Factor-α (TNF-α)-308 G/A Polymorphism is Associated with Increased Sepsis Mortality in Ventilated Very Low Birth Weight (VLBW) Infants, Southern Regional Meeting, Southern, New Orleans, Louisiana | 2004 |
| Poster Presentation, The TNFα -308, MCP-1 -2518 and TGFβ1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants., Pediatric Academic Societies’ Annual Meeting, Seattle, Washington | 05/2003 |
| Poster Presentation, The TNF-α-308 gene polymorphism is not associated with the development of chronic lung disease in very low birth weight (VLBW) infants., Southern Regional Meeting, Southern Society for Pediatric Research, New Orleans, Louisiana | 02/2003 |
| Poster Presentation, The effect of inhaled fluticasone (Flovent®) on tracheal aspirate (TA) concentrations of cytokines in very low birth weight infants, Southern Regional Meeting, Southern Society for Pediatric Research, New Orleans, Louisiana | 02/2003 |
| National and International Invited Seminars/Lectures, The TNF-α-308 gene polymorphism is not associated with the development of chronic lung disease in very low birth weight (VLBW) infants., Neonatal Symposium, Winnipeg, Mabitoba, Canada | 2003 |
| National and International Invited Seminars/Lectures, The Tumor Necrosis Factor-α (TNF-α)-308 Polymorphism is Associated with Increased Sepsis Mortality in Ventilated Very Low Birth Weight (VLBW) Infants., Neonatal Symposium, Winnipeg, Mabitoba, Canada | 2003 |
| State/Local Invited Seminars/Lectures, “Pediatric Clinical Research – Dead or Alive.”, Pediatric Faculty Meeting, University of Mississippi Medical Center | 2003 |
| Regional Invited Seminars/Lectures, State of clinical research at The University of Mississippi, Inaugural Pediatric MAGICS Group Meeting, Birmingham, Alabama | 2003 |
| Regional Invited Seminars/Lectures, Platelet Derived Growth Factor BB is Increased in Infants Who Develop Broncho pulmonary Dysplasia, Southern Regional Meeting, Southern Society for Pediatric Research, New Orleans, Louisiana | 2002 |
| State/Local Invited Seminars/Lectures, “Carbamazepine Ingestion.”, Pediatric Case Conference, University of Mississippi Medical Center | 2002 |
| Regional Invited Seminars/Lectures, Predose Vital Signs Predict the Effect of Nifedipine on Blood Pressure and Heart Rate in Normotensive Adults, Southern Regional Meeting, Southern Society for Pediatric, New Orleans, Louisiana | 2002 |
| Poster Presentation, Pharmacokinetics of a New Nifedipine Suspension in Young Adults, 2001 Annual Meeting, American College of Clinical Pharmacy, Tampa, Florida | 10/2001 |
| Regional Invited Seminars/Lectures, “Development of a Pediatric Nifedipine Formulation.”, Pediatric Grand Rounds LSUHSC-Shreveport, Shreveport, Louisiana | 2001 |
| Regional Invited Seminars/Lectures, “Patient/Parent Asthma Education in the Physician’s Office Room.”, Pediatric Spring Review –II, LSUHSC-Shreveport, Shreveport, Louisiana | 1999 |
| Regional Invited Seminars/Lectures, “Practical Guide To Managing Asthma.”, 10th Annual Conference on Women’s and Children’s Health, Shreveport, Louisiana | 1999 |
| Regional Invited Seminars/Lectures, “Attention Deficit Hyperactivity Disorder: Role of Medications.”, 10th Annual Conference on Women’s and Children’s Health, Shreveport, Louisiana | 1999 |
| Poster Presentation, Clinical Pathway for Vancomycin Use in Pediatric Patients with Fever and Neutropenia, 1998 Spring Clinical Meeting, American College of Clinical Pharmacy, Palm Springs, CA | 04/1998 |
| National and International Invited Seminars/Lectures, “Special Topics in Pediatric Therapeutics: Drug Therapy Used to Manage Neurological Disorders.”, Advanced Pharmacology Series: Competencies and Challenges in Ambulatory Care Practice, Chapel Hill, North Carolina | 1998 |
| National and International Invited Seminars/Lectures, “Special Topics in Pediatric Therapeutics: Drug Therapy Used To Manage GI/GU Conditions.”, Advanced Pharmacology Series: Competencies and Challenges in Ambulatory Care Practice, Chapel Hill, North Carolina | 1998 |
| Regional Invited Seminars/Lectures, “Fever and Neutropenia Clinical Pathway: Evaluation of Vancomycin Use.”, Southeastern Residency Conference, Athens, GA | 1998 |
| Poster Presentation, Sedation Practices in Neonatal Intensive Care Units, American Society Health System Pharmacists Midyear Clinical Meeting, Atlanta, GA | 12/1997 |
| Poster Presentation, Vancomycin Use in Pediatric Patients with Fever and Neutropenia, American Society Health-System Pharmacists Midyear Clinical Meeting, New Orleans, LA | 12/1996 |
Honors, Awards, and Recognition
| University of Mississippi Medical Center Leadership Development Program 2011-2012 Class, University of Mississippi Medical Center | 2011 |
| 2010 Research Day Poster Competition, 2nd Place, University of Mississippi Medical Center, School of Medicine | 2010 |
| Faculty Research Fellows Class of 2003, University of Mississippi | 2003 |
| Pediatrics Research Award Recipient 2003, UMC Department of Pediatrics | 2003 |
| W. B. Saunders Physiology Award, University of Mississippi Medical Center | 1995 |
| Phi Kappa Phi Honor Society, University of Mississippi | 1993 |
| Rho Chi National Pharmacy Honor Society, University of Mississippi | 1993 |
| Golden Key National Honor Society, Golden Key | 1990 |
Professional Membership and Service
| American Association of Colleges of Pharmacy, Pharmacy Practice Section, Faculty Development Committee, Committee Member | 2012 - Present |
| Pediatric Pharmacy Advocacy Group, Member | 2008 - 2009 |
| Mississippi College of Clinical Pharmacy, Judge, Student Seminar Competition | 2007 |
| Mississippi College of Clinical Pharmacy, Chairperson | 2005 - 2006 |
| Mississippi College of Clinical Pharmacy, Judge, Student Seminar Competition | 2005 |
| Japanese Scholar Exchange Program, Preceptor | 2004 - 2007 |
| Bruce Parks Endowment Scholarship Steering Committee, Chairperson | 2003 - Present |
| American Association of Colleges of Pharmacy, Member | 2002 - Present |
| Mississippi College of Clinical Pharmacy, Member | 2002 - Present |
| American College of Clinical Pharmacy, Pediatric PRN, Member | 2002 - Present |
| Association of Clinical Research Professionals, Member | 2000 - Present |
| Therapeutic Drug Monitoring, Reviewer, Journal Article | 1998 - 2002 |
| Clinical Pharmacology and Therapeutics, Reviewer, Journal Article | 1998 - 2002 |
| Journal of Clinical Pharmacology, Reviewer, Journal Article | 1998 - 2002 |
| Journal of Pediatrics, Reviewer, Journal Article | 1998 - 2002 |
| Pediatrics, Reviewer, Journal Article | 1998 - Present |
| American College of Clinical Pharmacy, Member | 1996 - Present |
Committee Service
| University of Mississippi Medical Center, Interprofessional Education Committee, Member | 2013 - Present |
| University of Mississippi, School of Pharmacy, Reorganization Task Force, Member | 2013 - Present |
| University of Mississippi Medical Center, Department of Pediatrics, Discovery Council, Member | 2013 - Present |
| University of Mississippi, School of Pharmacy, Executive Council, Member | 2012 - Present |
| University of Mississippi, School of Pharmacy, Faculty Governance Task Force, Chair | 2012 - Present |
| University of Mississippi, School of Pharmacy, Faculty Council, Chair | 2012 - Present |
| University of Mississippi, School of Pharmacy, Research and Graduate Affairs Committee, Member | 2012 - Present |
| School Of Medicine - Promotions and Tenure, Member | 2012 - Present |
| University of Mississippi, School of Pharmacy, Associate Dean of Academic Affairs Search Committee, Member | 2012 - 2013 |
| Medical Center - Academic Council, Member | 2011 - Present |
| UM, School of Pharmacy, Directors Committee, Member | 2011 - Present |
| University of Mississippi, School of Pharmacy, Skills Lab Renovation Sub-Committee, Member | 2011 - 2012 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice Pre-APPE Ad Hoc Committee, Member | 2011 - 2012 |
| UM, School of Pharmacy, Internal Transition Committee, Chair | 2011 - Present |
| UMC, Interprofessional Education SubCommittee, Member | 2011 - 2013 |
| UMC, Research Compliance Education Task Force, Member | 2011 - 2013 |
| University of Mississippi, Ad Hoc Grades Appeal Committee, Member | 2011 - 2011 |
| University of Mississippi, Tenure and Promotion Committee, Member | 2010 - 2013 |
| University of Mississippi, School of Pharmacy, PhD/PharmD Task Force, Member | 2010 - 2012 |
| University of Mississippi, School of Pharmacy, Faculty Council, Member | 2009 - Present |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Faculty Search Committee, Member | 2009 - Present |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Education Leadership Committee, Chair | 2009 - Present |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Pathway Committee, Member | 2009 - Present |
| University of Mississippi, School of Pharmacy, ACPE Self-Study Organization and Administration Subcommittee, Member | 2009 - 2012 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Group Course Committee, Member | 2009 - 2011 |
| UMC, Faculty Development Committee, Member | 2009 - Present |
| UMC, LINC Faculty Advisory Council, Member | 2009 - 2011 |
| Clinical Trials Task Force, Member | 2008 - 2009 |
| Clinical Research Space Task Force Committee, Member | 2007 - 2008 |
| University of Mississippi, School of Pharmacy, Accreditation Council for Pharmacy Education Faculty and Staff Subcommittee, Member | 2006 - 2007 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Faculty Search Committee, Member | 2005 - 2007 |
| Institutional Review Board Assent Policy Subcommittee, Chair | 2005 - 2008 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Facilitator Evaluation of Student Tool Review Committee, Member | 2005 - 2005 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Rotating Facilitator Review Committee, Chair | 2005 - 2005 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Case Management Conference Review Committee, Member | 2005 - 2005 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Tenure and Promotion Policy Committee, Chair | 2005 - 2005 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Dress Code Review Committee, Member | 2005 - 2005 |
| Medical Center - Institutional Review Board 2, Member | 2004 - Present |
| University of Mississippi, School of Pharmacy, Accreditation Council for Pharmacy Education, Self-Study Physical Facilities Subcommittee, Member | 2004 - 2004 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice Content Exam Committee, Member | 2003 - 2008 |
| University of Mississippi, School of Pharmacy, Department of Pharmacy Practice, Pharmaceutical Care Course Director Committee, Member | 2003 - 2007 |
| University of Mississippi, School of Pharmacy, PBL Writing Group, Descriptive Report of Group Assessment Tool, Member | 2003 - 2004 |
| Clinical Research Education and Training Adhoc Committee, Member | 2003 - 2004 |
| Department of Pediatrics Research Committee, Member | 2002 - 2013 |
Community Service
| Jackson Prep Science Symposium, Presenter | 01/2013 - 01/2013 |
| Mississippi Region VII Science Fair, Judge | 03/2011 - 03/2011 |
Other Service
| School of Dentistry, Junior Faculty Mentorship Committee, Dr. Lubna Fawad, Mentor | 07/2008 - 06/2009 |
| School of Denistry Student Poster Session, Judge | 2008 - 2008 |
| Pediatric Clinical Research, Director | 05/2002 - Present |
Teaching Experience
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2013 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2012 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2012 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2012 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2011 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2011 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2013 - 2013 |
| 335, Pharmacy, Course, Lecturer, Clinical Laboratory Data Analysis | Spring 2013 - 2013 |
| 569, Pharmacy, Course, Grader, Pharmaceutical Care IV | Spring 2013 - 2013 |
| 569, Pharmacy, Small Group, Facilitor, Pharmaceutical Care IV | Spring 2013 - 2013 |
| 557, Pharmacy, Course, Grader, Pharmaceutical Care I | Fall 2012 - 2013 |
| 350, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2012 - 2012 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2012 |
| 335, Pharmacy, Lecture, Lecturer, Clinical Laboratory Data Analysis | Spring 2012 |
| 545, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty Elective | Spring 2012 |
| 569, Pharmacy, Small Group, Facilitor, Pharmaceutical Care IV | Spring 2012 |
| 350, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2011 |
| 557, Pharmacy, Small Group, Facilitor, Pharmaceutical Care I | Fall 2011 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2011 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2011 |
| 569, Pharmacy, Small Group, Facilitor, Pharmaceutical Care IV | Spring 2011 |
| 350, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2010 |
| 551, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2010 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Fall 2010 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2010 |
| 557, Pharmacy, Small Group, Facilitor, Pharmaceutical Care I | Fall 2010 |
| 560, Pharmacy, Small Group, Facilitor, Pharmaceutical Care II | Fall 2010 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2010 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2010 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Spring 2010 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2010 |
| 350, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2009 |
| 551, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2009 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Fall 2009 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2009 |
| 557, Pharmacy, Small Group, Facilitor, Pharmaceutical Care I | Fall 2009 |
| 560, Pharmacy, Small Group, Facilitor, Pharmaceutical Care II | Fall 2009 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric Research | Summer 2009 |
| 620, Nursing, Course, Lecturer, Compliance with Regulations in Clinical Trials and Research | Summer 2009 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2009 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2009 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric Research | Spring 2009 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Spring 2009 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2009 |
| 567, Pharmacy, Course, Moderator, Seminar Skills Dev for Health Professionals II | Spring 2009 |
| 551, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2008 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Fall 2008 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2008 |
| 557, Pharmacy, Small Group, Facilitor, Pharmaceutical Care I | Fall 2008 |
| 560, Pharmacy, Small Group, Facilitor, Pharmaceutical Care II | Fall 2008 |
| 566, Pharmacy, Course, Moderator, Seminar Skills Dev for Health Professionals | Fall 2008 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2008 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Spring 2008 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2008 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Fall 2007 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric Research | Fall 2007 |
| 551, Pharmacy, Course, Course Director, Information Skills in Pharmacy Practice | Fall 2007 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Fall 2007 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2007 |
| 560, Pharmacy, Small Group, Facilitor, Pharmaceutical Care II | Fall 2007 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2007 |
| 544, Pharmacy, Course, Preceptor, Longitudinal PHarmacy Practice: Specialty | Spring 2007 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2007 |
| 563, Pharmacy, Small Group, Facilitor, Pharmaceutical Care III | Spring 2007 |
| 569, Pharmacy, Course, Course Director, Pharmaceutical Care IV | Spring 2007 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Fall 2006 |
| 544, Pharmacy, Course, Preceptor, Longitudinal Pharmacy Practice: Specialty | Fall 2006 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2006 |
| 557, Pharmacy, Course, Course Director, Pharmaceutical Care I | Fall 2006 |
| 560, Pharmacy, Small Group, Facilitor, Pharmaceutical Care II | Fall 2006 |
| Medicine, Lecture, Lecturer, Neslon Lectures, Department of Pediatrics Residency Education | 2006 |
| 620, Nursing, Course, Lecturer, Compliance with Regulations in Clinical Trials and Research | Summer 2006 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2006 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2006 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric Research | Spring 2006 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2006 |
| 569, Pharmacy, Course, Course Director, Pharmaceutical Care IV | Spring 2006 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Fall 2005 |
| 551, Pharmacy, Course, Lecturer, Information Skills in Pharmacy Practice | Fall 2005 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2005 |
| 557, Pharmacy, Small Group, Facilitor, Pharmaceutical Care I | Fall 2005 |
| Medicine, Lecture, Lecturer, Nelson Lectures, Department of Pediatrics Residency Education | 2005 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Summer 2005 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2005 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Spring 2005 |
| 569, Pharmacy, Course, Course Director, Pharmaceutical Care IV | Spring 2005 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Fall 2004 |
| 551, Pharmacy, Course, Lecturer, Information Skills in Pharmacy Practice | Fall 2004 |
| Medicine, Lecture, Lecturer, Medical Student Lecture Series, Department of Pediatrics | Fall 2004 |
| 557, Pharmacy, Course, Course Director, Pharmaceutical Care I | Fall 2004 |
| Medicine, Lecture, Lecturer, Nelson Lectures, Department of Pediatrics Residency Education | 2004 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Spring 2004 |
| 569, Pharmacy, Course, Course Director, Pharmaceutical Care IV | Spring 2004 |
| 591, Pharmacy, Course, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Fall 2003 |
| 551, Pharmacy, Course, Lecturer, Information Skills in Pharmacy Practice | Fall 2003 |
| 557, Pharmacy, Course, Course Director, Pharmaceutical Care I | Fall 2003 |
| Medicine, Lecture, Lecturer, Nelson Lectures, Department of Pediatrics Residency Education | 2003 |
| 591, Pharmacy, Small Group, Preceptor, Advance Pharmacy Practice Experience: Pediatric | Summer 2003 |
| 563, Pharmacy, Course, Course Director, Pharmaceutical Care III | Spring 2003 |
| 569, Pharmacy, Small Group, Group Facilitator, Pharmaceutical Care IV | Spring 2003 |
| 560, Pharmacy, Small Group, Group Facilitator, Pharmaceutical Care II | Fall 2002 |
| Medicine, Lecture, Lecturer, Nelson Lectures, Department of Pediatrics Residency Education | 2002 |
Directed Student Learning
| Directed Individual/Independent Study, Advised: Trey Warnock | 2012 - 2017 |
| Directed Individual/Independent Study, Advised: Mary Wooten | 2012 - 2016 |
| Directed Individual/Independent Study, Advised: Alex Raymond | 2012 - 2016 |
| Directed Individual/Independent Study, Advised: Brian Chaney | 2012 - 2016 |
| Directed Individual/Independent Study, Advised: Kayla Snow | 2012 - 2016 |
| Directed Individual/Independent Study, Advised: Lacey Williams | 2011 - 2016 |
| Directed Individual/Independent Study, Evaluating Dosage vs. Therapeutic Range of Vancomycin in Pediatric Patients Advised: Ashley Hale | 2011 - 2015 |
| Directed Individual/Independent Study, What is the quality of life of Mississippi pharmacists? Advised: Meredith Cole | 2011 - 2015 |
| Directed Individual/Independent Study, Assessing Consumer Knowledge on Community Pharmacist’s Responsibilities Based on Educational Status Advised: Katherine Conerly Clark | 2011 - 2015 |
| Seminar Advisor, Advised: Amanda Harper, Megan Stoiber | 2010 - 2011 |
| Directed Individual/Independent Study, Treating Fungal Respiratory Infections in Cystic Fibrosis Patients Advised: Cynthia Tran | 2010 - 2013 |
| Directed Individual/Independent Study, An Assessment of Current Vitamin D Supplementation Dosing and Its Effectiveness in Patients with Cystic Fibrosis Advised: Adrian Turner | 2010 - 2014 |
| Directed Individual/Independent Study, Differences in Perceptions About Research Among Pediatric Cystic Fibrosis Patients and Their Parents Advised: Ann Clark Gannaway | 2010 - 2013 |
| Directed Individual/Independent Study, Compliance Rate of Medications in a Retail Pharmacy Advised: Emily Calogne | 2010 - 2013 |
| Directed Individual/Independent Study, Lost in Translation: Assessing the Accuracy of Mississippi Community Pharmacists in Translating Prescription Labels From English to Vietnamese Advised: Hoang Long | 2010 - 2014 |
| Directed Individual/Independent Study, Patient’s Perceptions of Pharmacists’ Role in Providing Valued Health Care and MTM Services. Advised: Lauren Freeman | 2010 - 2013 |
| Directed Individual/Independent Study, Assessing the Knowledge of Primary Caregivers about Flavoring for Liquid Medications for Children Advised: Lindsey Corbin | 2010 - 2013 |
| Directed Individual/Independent Study, Pilot Study of Factors Leading to Asthma Exacerbations and Hospitalizations in a Pediatric Population. Advised: Sara Roberts | 2010 - 2013 |
| Directed Individual/Independent Study, Assessing Prior Knowledge of Inhaler Technique Advised: Lauren Brady | 2010 - 2014 |
| Supervised Research, Readability of Informed Consent Documents Advised: Brian McCrate | 2010 - 2010 |
| Seminar Advisor, Advised: Matt Dabbs, Jamie Jelks | 2010 - 2010 |
| Advised: | 2010 - 2010 |
| Seminar Advisor, Advised: | 2009 - 2009 |
| Seminar Advisor, Advised: | 2009 - 2009 |
| Seminar Advisor, Advised: | 2008 - 2008 |
| Supervised Research, Blood Pressure Measurements in the POPD Advised: Laura Laird | 2008 - 2008 |
| Seminar Advisor, Advised: | 2007 - 2007 |
| Seminar Advisor, Advised: | 2006 - 2006 |
| Seminar Advisor, Advised: | 2004 - 2004 |
| Directed Individual/Independent Study, Advised: | 2004 - 2006 |
Residency Training
| UMC ASHP Accredited Pharmacy Practice Residency, Training Faculty | 2005 - 06/2006 |